Akston Biosciences Corporation
-
Akston Biosciences ends vaccine partnership with Stelis Biopharma
Akston has reclaimed all rights to AKS-452, a room temperature stable, low-cost, protein subunit COVID-19 vaccine Akston Biosciences Corporation, a…
Read More »